| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |